Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
The Effects of Combining Manual Soft Tissue Release and Physical Exercise Training on Lung Function(LF), Exercise Capacity(EC), and Cardiac Autonomic Function(CAF) in Moderate to Severe COPD: A Randomized Controlled Trial
Verified date | April 2024 |
Source | National Cheng Kung University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The potential effects of combining manual soft tissue release and physical exercise training on lung function, exercise capacity, and cardiac autonomic function in patients with moderate and severe chronic obstructive pulmonary disease were investigated.
Status | Completed |
Enrollment | 70 |
Est. completion date | February 2, 2024 |
Est. primary completion date | February 2, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years to 80 Years |
Eligibility | Inclusion Criteria: - GOLD grade II~IV - Stable condition - No acute exacerbations in 6 weeks Exclusion Criteria: - Acute heart failure and, or arrhythmia - Pulmonary arterial hypertension - Skeletal and, or neuromuscular disorders - Chest surgery - Untreated or uncontrolled conditions - Rheumatoid conditions - Depends on oxygen supply |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Cheng Kung University | Tainan |
Lead Sponsor | Collaborator |
---|---|
National Cheng Kung University |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Forced expiratory volume in 1 s (FEV1) | FEV1 is measured by the lung function test, and the unit presented will be in percent and liter. | Change from baseline (0 week) to follow-up (12 weeks) | |
Primary | forced vital capacity (FVC) | FVC is measured by the lung function test, and the unit presented will be in percent and liter. | Change from baseline (0 week) to follow-up (12 weeks) | |
Primary | FEV1/FVC ratio | FEV1/FVC ratio is measured by the lung function test, and the unit presented will be in percent. | Change from baseline (0 week) to follow-up (12 weeks) | |
Primary | expiratory reserve volume (ERV) | ERV is measured by the lung function test, and the unit presented will be in liter. | Change from baseline (0 week) to follow-up (12 weeks) | |
Primary | functional residual capacity (FRC) | FRC is measured by the lung functions test, and the unit presented will be in liters. | Change from baseline (0 week) to follow-up (12 weeks) | |
Primary | inspiratory capacity (IC) | IC is measured by the lung functions test, and the unit presented will be in liters. | Change from baseline (0 week) to follow-up (12 weeks) | |
Primary | inspiratory reserve volume (IRV), | IRV is measured by the lung functions test, and the unit presented will be in liters. | Change from baseline (0 week) to follow-up (12 weeks) | |
Primary | residual volume (RV) | RV is measured by the lung function test, and the unit presented will be in liters. | Change from baseline (0 week) to follow-up (12 weeks) | |
Primary | total lung capacity (TLC) | TLC is measured by the lung function test, and the unit presented will be in liters. | Change from baseline (0 week) to follow-up (12 weeks) | |
Primary | tidal volume (TV) | TV is measured by the lung function test, and the unit presented will be in liters. | Change from baseline (0 week) to follow-up (12 weeks) | |
Primary | vital capacity (VC) | VC is measured by the lung function test, and the unit presented will be in liters. | Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | Rate of perceived exertion (RPE) | RPE is measured by the cardiopulmonary exercise test. This scale ranges from 0 (very light activity) to 10 (maximum effort activity). | Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | Oxygen consumption (VO2) | VO2 is measured by the cardiopulmonary exercise test, and the unit presented will be in milliliters of oxygen consumed per minute (ml/min). | Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | oxygen saturation | oxygen saturation is measured by the oximeter, and the unit presented will be in percent | Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | heart rate (HR) | HR is measured by cardiopulmonary exercise test, and the unit presented will be in beat per minute (BPM) | Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | blood pressure (BP) | BP is measured by the cardiopulmonary exercise test, which is divided into two parameters: systolic blood pressure (SBP) and diastolic blood pressure (DBP).
The unit presented will be in millimeters of mercury (mmHg). |
Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | Diaphragmatic mobility | Diaphragmatic mobility is measured by the ultrasound, and the unit presented will be in millimeters | Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | Cardiac Autonomic Function | Cardiac Autonomic Function is measured by heart rate variability of electrocardiography, and the unit presented will be in millisecond (ms) and millisecond square (ms2) | Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | six minute walk test (6-MWT) | 6-MWT assesses the distance a person can walk within 6 minutes, and the unit presented will be in meters. | Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | maximal expiratory pressure (MEP) | MEP is measured by the pressure meter, and the unit presented will be in centimetre of water (cmH2O). | Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | maximal inspiratory pressure (MIP) | MIP is measured by the pressure meter, and the unit presented will be in centimetre of water (cmH2O). | Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | St. George's Respiratory Questionnaire (SGRQ) | SGRQ is assessing how obstructive airway disease affects overall health, daily life, and well-being. Scores range from 0 to 100, with higher scores indicating more limitations. | Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | fatigue severity scale (FSS) | FSS is assessing the impact of fatigue on a person's activity and lifestyle. There are nine items, and each item is scored from 1 to 9 (strongly disagree to strongly agree).
Higher total scores indicate more severe fatigue. |
Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | Modified Medical Research Council (mMRC) | mMRC is assessing the subjective degree of breathlessness by patients during physical activity. It rates on a scale from 0 to 4, with a higher rate indicating the worst possible shortness of breath. | Change from baseline (0 week) to follow-up (12 weeks) | |
Secondary | 36-Item Short Form Health Survey (SF-36) | SF-36 is assessing the subjective survey health status and quality of life. It consists of eight sections, with scores ranging from 0 to 100. Higher scores indicate better health and less disability. | Change from baseline (0 week) to follow-up (12 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|